WASHINGTON, Nov. 30, 2016 /PRNewswire-USNewswire/ -- As of noon EST today, the www.KratomComments.org Web site organized by the American Kratom Association (AKA) had generated 12,875 comments to the U.S. Drug Enforcement Administration (DEA) ahead of its 11:59 p.m. EST December 1st comment period deadline.
Input from KratomComments.org is cascading in so quickly into the DEA's Regulation.gov comment form that the federal agency's official count was lagging at 11,382 as of noon EST today. AKA created the KratomComments.org website in October 2016 to make it easier for consumers to submit their comments to the DEA. The site has proven so popular that 1,436 comments – more than a tenth of all comments received so far - were submitted on November 29th alone.
AKA is working hard to get as many people as possible who have benefited from kratom to share their opposition to the classification of the coffee-like herb as a Schedule I drug.
American Kratom Association Director Susan Ash said: "We are delighted that people used what we provided to make submitting comments easier. If you've already sent your comments in to the DEA directly or through KratomComments.org, please make it your mission today to find five other people in the kratom community, and/or family members who have witnessed positive changes in your life as a result of kratom, and encourage them to send in comments. We need to make sure our voices cannot be ignored. I am appealing to you -- to each and every one of you with a story like my own -- to help get this done."
The KratomComments.org website simplifies the process of submitting comments to the DEA through Regulations.gov and also provides kratom community members with an assurance that there will be an independent record of their submissions – one that is not subject to federal computer problems (as were experienced shortly after the comment period opened) or any concerns about "missing" or otherwise "lost" comment submissions to the DEA.
The American Kratom Association is proud to have been instrumental in helping to coordinate the broad-based national opposition to the DEA's attempt to effectively ban kratom. In addition to creating KratomComments.org, AKA also:
- Conducted in November 2016 an online survey of 105 emergency room (ER)/trauma health care professionals that found zero reported cases of deaths related to kratom. The new poll of America's front-line medical professionals also uncovered precisely zero percent support among those surveyed for a DEA ban on the coffee-like herb kratom.
- Encouraged a set of two letters sent on October 1st by a politically diverse group of 11 Senators, including Sen. Orrin G. Hatch (R-UT), Sen. Ron Wyden (D-OR) and Sen. Cory Booker (D-NJ), calling on the DEA to halt the proposed scheduling and allow for a regular rulemaking process permitting the public, scientific experts, and Congress to provide input.
- Facilitated letters to the DEA and the Office of Management and Budget sent on September 26th by a bipartisan group of 51 U.S. House Members urging a halt to the DEA's push to ban kratom.
- Worked with the Pain News Network on a September survey of 6150 kratom users about their experience with the herb.
- Promoted a successful and widely publicized September 14th "March for Kratom" in September at the White House.
- Circulated a "We The People" petition targeting the White House that has accumulated more than 142,000 signatures to date.
The America Kratom Association, a consumer-based non-profit organization, is here to set the record straight, giving voice to those suffering and protecting our rights to possess and consume kratom. AKA represents tens of thousands of Americans, each of whom have a unique story to tell about the virtues of kratom and its positive effects on their lives. www.americankratom.org
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/in-major-outpouring-of-support-13000-comments-submitted-to-dea-via-kratomcommentsorg-to-keep-kratom-legal-300370818.html
SOURCE American Kratom Association, Washington, D.C.